- Report
- May 2024
- 420 Pages
Global
From €2646EUR$3,000USD£2,290GBP
- Report
- February 2024
- 50 Pages
Global
From €2117EUR$2,400USD£1,832GBP
- Report
- December 2023
- 220 Pages
Global
From €2910EUR$3,300USD£2,519GBP
- Report
- October 2023
- 420 Pages
Global
From €2558EUR$2,900USD£2,214GBP
- Report
- March 2023
- 300 Pages
Global
From €2469EUR$2,800USD£2,138GBP
- Report
- June 2022
- 1500 Pages
Global
From €3440EUR$3,900USD£2,978GBP
- Drug Pipelines
- May 2022
- 400 Pages
Global
From €2646EUR$3,000USD£2,290GBP
- Report
- February 2022
- 360 Pages
United States
From €3175EUR$3,600USD£2,748GBP
- Report
- November 2021
- 222 Pages
Global
From €2646EUR$3,000USD£2,290GBP
- Report
- October 2021
- 78 Pages
Global
From €706EUR$800USD£611GBP
- Report
- January 2024
- 140 Pages
Global
From €2910EUR$3,300USD£2,519GBP
- Report
- October 2022
- 510 Pages
China
From €2117EUR$2,400USD£1,832GBP
- Report
- October 2019
Global
From €2469EUR$2,800USD£2,138GBP
- Report
- September 2023
Global
From €4366EUR$4,950USD£3,779GBP
- Report
- January 2023
- 356 Pages
Global
From €4366EUR$4,950USD£3,779GBP
- Report
- July 2024
- 476 Pages
Global
From €4366EUR$4,950USD£3,779GBP
- Report
- September 2022
- 240 Pages
Global
From €4895EUR$5,550USD£4,237GBP
- Report
- March 2024
- 181 Pages
Global
From €2161EUR$2,450USD£1,871GBP
- Report
- May 2023
United States
From €1323EUR$1,500USD£1,145GBP
- Report
- March 2023
Germany
From €1323EUR$1,500USD£1,145GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more